• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anemia in CKD in Primary Care: Executive Summary.

作者信息

Brunton Stephen, Fishbane Steven, Goldman Jennifer D, Wright Eugene

机构信息

Primary Care Metabolic Group, Winnsboro, SC.

Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY.

出版信息

Clin Diabetes. 2022 Winter;41(1):81-84. doi: 10.2337/cd22-0054. Epub 2022 Sep 9.

DOI:10.2337/cd22-0054
PMID:36714249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9862318/
Abstract
摘要

相似文献

1
Anemia in CKD in Primary Care: Executive Summary.基层医疗中慢性肾脏病患者的贫血：执行摘要
Clin Diabetes. 2022 Winter;41(1):81-84. doi: 10.2337/cd22-0054. Epub 2022 Sep 9.
2
Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data.慢性肾脏病和贫血对健康相关生活质量及工作生产力的影响：多国真实世界数据分析
BMC Nephrol. 2020 Mar 7;21(1):88. doi: 10.1186/s12882-020-01746-4.
3
Patient and Care Partner Burden in CKD Patients With and Without Anemia: A US-Based Survey.患有和未患贫血的慢性肾脏病患者的患者及护理伙伴负担：一项基于美国的调查
Kidney Med. 2022 Mar 7;4(4):100439. doi: 10.1016/j.xkme.2022.100439. eCollection 2022 Apr.
4
Poor recognition and undertreatment of anemia in patients with chronic kidney disease managed in primary care.在基层医疗机构管理的慢性肾脏病患者中，贫血的识别和治疗不足。
J Intern Med. 2023 Nov;294(5):628-639. doi: 10.1111/joim.13702. Epub 2023 Aug 4.
5
The prevalence and recognition of chronic kidney disease and anemia in long-term care residents.长期护理机构居民中慢性肾脏病和贫血的患病率及认知情况。
Consult Pharm. 2012 Sep;27(9):627-40. doi: 10.4140/TCP.n.2012.627.
6
Improving Detection and Management of Anemia in CKD.改善 CKD 患者贫血的检测和管理。
J Fam Pract. 2022 Jul;71(6 Suppl):S23-S28. doi: 10.12788/jfp.0411.
7
Iron-Deficiency Anemia in CKD: A Narrative Review for the Kidney Care Team.慢性肾脏病中的缺铁性贫血：面向肾脏护理团队的叙述性综述
Kidney Med. 2023 May 25;5(8):100677. doi: 10.1016/j.xkme.2023.100677. eCollection 2023 Aug.
8
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics.非透析依赖性慢性肾脏病患者贫血治疗中 vadadustat 的心血管安全性和疗效：设计和基线特征。
Am Heart J. 2021 May;235:1-11. doi: 10.1016/j.ahj.2020.10.068. Epub 2020 Oct 30.
9
Prognostic impact of chronic kidney disease and anemia at admission on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction.急性心肌梗死直接经皮冠状动脉介入治疗入院时慢性肾脏病和贫血对住院结局的预后影响
Int Heart J. 2014;55(4):301-6. doi: 10.1536/ihj.13-367. Epub 2014 Jun 2.
10
Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: an overview.慢性肾脏病患者贫血的患病率、病因、后果及贫血纠正的临床和经济效益：综述
Am J Health Syst Pharm. 2007 Jul 1;64(13 Suppl 8):S3-7; quiz S23-5. doi: 10.2146/ajhp070181.

本文引用的文献

1
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.达普司他用于治疗未接受透析患者的贫血
N Engl J Med. 2021 Dec 16;385(25):2313-2324. doi: 10.1056/NEJMoa2113380. Epub 2021 Nov 5.
2
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.达普司他用于治疗透析患者的贫血
N Engl J Med. 2021 Dec 16;385(25):2325-2335. doi: 10.1056/NEJMoa2113379. Epub 2021 Nov 5.
3
A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study.罗沙司他治疗肾衰竭贫血的随机试验：SIERRAS研究
Kidney Int Rep. 2021 Apr 17;6(7):1829-1839. doi: 10.1016/j.ekir.2021.04.007. eCollection 2021 Jul.
4
Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES).罗沙司他治疗未透析慢性肾脏病患者贫血的 3 期、随机、开放标签、活性对照研究（多洛米蒂研究）。
Nephrol Dial Transplant. 2021 Aug 27;36(9):1616-1628. doi: 10.1093/ndt/gfab191.
5
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.维达列汀治疗透析患者贫血的安全性和疗效。
N Engl J Med. 2021 Apr 29;384(17):1601-1612. doi: 10.1056/NEJMoa2025956.
6
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.vadadustat 治疗贫血及非透析依赖性慢性肾脏病患者的疗效。
N Engl J Med. 2021 Apr 29;384(17):1589-1600. doi: 10.1056/NEJMoa2035938.
7
Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease.缺氧诱导因子脯氨酰羟化酶抑制剂在治疗慢性肾脏病贫血中的应用
Kidney Int Suppl (2011). 2021 Apr;11(1):8-25. doi: 10.1016/j.kisu.2020.12.002. Epub 2021 Mar 18.
8
Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology.慢性肾脏病贫血：研究、管理及转诊至肾脏病科的方案
Nefrologia (Engl Ed). 2018 Jan-Feb;38(1):8-12. doi: 10.1016/j.nefro.2017.09.004. Epub 2017 Nov 9.
9
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD.缺氧诱导因子脯氨酰羟化酶抑制剂：治疗慢性肾脏病患者贫血的一种新方法。
Am J Kidney Dis. 2017 Jun;69(6):815-826. doi: 10.1053/j.ajkd.2016.12.011. Epub 2017 Feb 24.
10
Prevalence of anemia in chronic kidney disease in the United States.美国慢性肾脏病患者贫血的患病率
PLoS One. 2014 Jan 2;9(1):e84943. doi: 10.1371/journal.pone.0084943. eCollection 2014.